Global Research Grade Plasmid 麻豆原创 Research Report 2024

Publication ID:

PB502242900

Publication Date:

February 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Research grade plasmids are plasmids produced under standard laboratory conditions with strict quality control for use in basic research and drug discovery studies.
The global Research Grade Plasmid market was valued at US$ 65 million in 2023 and is anticipated to reach US$ 115.8 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
North American market for Research Grade Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Research Grade Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Research Grade Plasmid in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Research Grade Plasmid include PlasmidFactory GmbH, Xpress Biologics, Charles River Laboratories, Sartorius AG, Catalent, Inc, TriLink BioTechnologies, WuXi Biologics (Cayman) Inc., Danaher and Akron Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Research Grade Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Research Grade Plasmid.
Report Scope
The Research Grade Plasmid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Research Grade Plasmid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Research Grade Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
PlasmidFactory GmbH
Xpress Biologics
Charles River Laboratories
Sartorius AG
Catalent, Inc
TriLink BioTechnologies
WuXi Biologics (Cayman) Inc.
Danaher
Akron Biotech
GenScript Biotech Corporation
KromaTiD
Segment by Type
Linear Plasmid
Baculovirus Plasmid
Others
Segment by Application
Gene Therapy
Vaccine Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Research Grade Plasmid companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Research Grade Plasmid 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Linear Plasmid
1.2.3 Baculovirus Plasmid
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Research Grade Plasmid 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Vaccine Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Research Grade Plasmid 麻豆原创 Perspective (2019-2030)
2.2 Research Grade Plasmid Growth Trends by Region
2.2.1 Global Research Grade Plasmid 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Research Grade Plasmid Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Research Grade Plasmid Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Research Grade Plasmid 麻豆原创 Dynamics
2.3.1 Research Grade Plasmid Industry Trends
2.3.2 Research Grade Plasmid 麻豆原创 Drivers
2.3.3 Research Grade Plasmid 麻豆原创 Challenges
2.3.4 Research Grade Plasmid 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Research Grade Plasmid Players by Revenue
3.1.1 Global Top Research Grade Plasmid Players by Revenue (2019-2024)
3.1.2 Global Research Grade Plasmid Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Research Grade Plasmid 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Research Grade Plasmid Revenue
3.4 Global Research Grade Plasmid 麻豆原创 Concentration Ratio
3.4.1 Global Research Grade Plasmid 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Research Grade Plasmid Revenue in 2023
3.5 Research Grade Plasmid Key Players Head office and Area Served
3.6 Key Players Research Grade Plasmid Product Solution and Service
3.7 Date of Enter into Research Grade Plasmid 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Research Grade Plasmid Breakdown Data by Type
4.1 Global Research Grade Plasmid Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Research Grade Plasmid Forecasted 麻豆原创 Size by Type (2025-2030)
5 Research Grade Plasmid Breakdown Data by Application
5.1 Global Research Grade Plasmid Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Research Grade Plasmid Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Research Grade Plasmid 麻豆原创 Size (2019-2030)
6.2 North America Research Grade Plasmid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Research Grade Plasmid 麻豆原创 Size by Country (2019-2024)
6.4 North America Research Grade Plasmid 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Research Grade Plasmid 麻豆原创 Size (2019-2030)
7.2 Europe Research Grade Plasmid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Research Grade Plasmid 麻豆原创 Size by Country (2019-2024)
7.4 Europe Research Grade Plasmid 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Research Grade Plasmid 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Research Grade Plasmid 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Research Grade Plasmid 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Research Grade Plasmid 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Research Grade Plasmid 麻豆原创 Size (2019-2030)
9.2 Latin America Research Grade Plasmid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Research Grade Plasmid 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Research Grade Plasmid 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Research Grade Plasmid 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Research Grade Plasmid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Research Grade Plasmid 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Research Grade Plasmid 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PlasmidFactory GmbH
11.1.1 PlasmidFactory GmbH Company Detail
11.1.2 PlasmidFactory GmbH Business Overview
11.1.3 PlasmidFactory GmbH Research Grade Plasmid Introduction
11.1.4 PlasmidFactory GmbH Revenue in Research Grade Plasmid Business (2019-2024)
11.1.5 PlasmidFactory GmbH Recent Development
11.2 Xpress Biologics
11.2.1 Xpress Biologics Company Detail
11.2.2 Xpress Biologics Business Overview
11.2.3 Xpress Biologics Research Grade Plasmid Introduction
11.2.4 Xpress Biologics Revenue in Research Grade Plasmid Business (2019-2024)
11.2.5 Xpress Biologics Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Research Grade Plasmid Introduction
11.3.4 Charles River Laboratories Revenue in Research Grade Plasmid Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 Sartorius AG
11.4.1 Sartorius AG Company Detail
11.4.2 Sartorius AG Business Overview
11.4.3 Sartorius AG Research Grade Plasmid Introduction
11.4.4 Sartorius AG Revenue in Research Grade Plasmid Business (2019-2024)
11.4.5 Sartorius AG Recent Development
11.5 Catalent, Inc
11.5.1 Catalent, Inc Company Detail
11.5.2 Catalent, Inc Business Overview
11.5.3 Catalent, Inc Research Grade Plasmid Introduction
11.5.4 Catalent, Inc Revenue in Research Grade Plasmid Business (2019-2024)
11.5.5 Catalent, Inc Recent Development
11.6 TriLink BioTechnologies
11.6.1 TriLink BioTechnologies Company Detail
11.6.2 TriLink BioTechnologies Business Overview
11.6.3 TriLink BioTechnologies Research Grade Plasmid Introduction
11.6.4 TriLink BioTechnologies Revenue in Research Grade Plasmid Business (2019-2024)
11.6.5 TriLink BioTechnologies Recent Development
11.7 WuXi Biologics (Cayman) Inc.
11.7.1 WuXi Biologics (Cayman) Inc. Company Detail
11.7.2 WuXi Biologics (Cayman) Inc. Business Overview
11.7.3 WuXi Biologics (Cayman) Inc. Research Grade Plasmid Introduction
11.7.4 WuXi Biologics (Cayman) Inc. Revenue in Research Grade Plasmid Business (2019-2024)
11.7.5 WuXi Biologics (Cayman) Inc. Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Research Grade Plasmid Introduction
11.8.4 Danaher Revenue in Research Grade Plasmid Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Akron Biotech
11.9.1 Akron Biotech Company Detail
11.9.2 Akron Biotech Business Overview
11.9.3 Akron Biotech Research Grade Plasmid Introduction
11.9.4 Akron Biotech Revenue in Research Grade Plasmid Business (2019-2024)
11.9.5 Akron Biotech Recent Development
11.10 GenScript Biotech Corporation
11.10.1 GenScript Biotech Corporation Company Detail
11.10.2 GenScript Biotech Corporation Business Overview
11.10.3 GenScript Biotech Corporation Research Grade Plasmid Introduction
11.10.4 GenScript Biotech Corporation Revenue in Research Grade Plasmid Business (2019-2024)
11.10.5 GenScript Biotech Corporation Recent Development
11.11 KromaTiD
11.11.1 KromaTiD Company Detail
11.11.2 KromaTiD Business Overview
11.11.3 KromaTiD Research Grade Plasmid Introduction
11.11.4 KromaTiD Revenue in Research Grade Plasmid Business (2019-2024)
11.11.5 KromaTiD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

PlasmidFactory GmbH
Xpress Biologics
Charles River Laboratories
Sartorius AG
Catalent, Inc
TriLink BioTechnologies
WuXi Biologics (Cayman) Inc.
Danaher
Akron Biotech
GenScript Biotech Corporation
KromaTiD

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.